MRS2-F Antibody

What is MRS2 protein and why are antibodies against it important for research?

MRS2 is a mitochondrial magnesium transport protein located in the inner mitochondrial membrane that plays a critical role in magnesium homeostasis essential for mitochondrial integrity and function. The human MRS2 protein contains two transmembrane domains that form a pore on the inner mitochondrial membrane, with most of the protein residing within the mitochondrial matrix .

MRS2-F antibodies are vital research tools for:

• Detecting MRS2 expression levels in various tissues and cell types

• Investigating subcellular localization via immunofluorescence microscopy

• Studying protein-protein interactions through co-immunoprecipitation

• Analyzing post-translational modifications like N-glycosylation

• Examining structural changes related to channel regulation

What are the validated methods for confirming MRS2-F antibody specificity?

Antibody specificity should only be assigned when reactivity is demonstrated with at least two examples of target protein . For MRS2-F antibody, researchers should:

• Perform Western blotting with positive controls (cells expressing MRS2) and negative controls (MRS2 knockdown cells)

• Use immunofluorescence to confirm mitochondrial localization patterns

• Compare results with commercially available anti-MRS2 antibodies targeting different epitopes

• Test reactivity in MRS2-overexpressing systems versus control cells

• Validate with recombinant MRS2 protein including the target epitope

• Conduct adsorption and elution studies to confirm binding characteristics

How can MRS2-F antibody be employed to study N-glycosylation of MRS2?

Recent research has revealed that MRS2 exists in both N-glycosylated and unglycosylated isoforms in mitochondria from various mammalian sources . To study this phenomenon:

• Use MRS2-F antibody for immunoblotting to detect the higher and lower molecular weight bands corresponding to glycosylated and unglycosylated forms

• Confirm glycosylation status by treating samples with peptide:N-glycosidase F (PNGase F) and observing the gel shift

• Combine with lectin affinity methods using concanavalin A or Lens culinaris agglutinin

• Track changes in glycosylation patterns after treating cells with N-glycosylation inhibitors like tunicamycin

• Correlate glycosylation status with functional Mg²⁺ transport capacity

How should researchers design experiments to investigate MRS2 oligomerization states using MRS2-F antibody?

MRS2 forms a pentameric channel structure with complex oligomerization dynamics affected by divalent cations. To study these structures:

• Perform chemical crosslinking followed by immunoblotting with MRS2-F antibody

• Use native PAGE conditions that preserve protein complexes

• Include varying concentrations of divalent cations (Mg²⁺, Ca²⁺, Co²⁺) in experimental buffers

• Note that while Mg²⁺ and Ca²⁺ suppress oligomerization of the MRS2 NTD, they don't affect full-length MRS2 assembly

• Consider that MRS2 matrix domains interact with ~μM affinity, which is weakened by up to two orders of magnitude in the presence of Mg²⁺

What considerations are important when using MRS2-F antibody to study the D216Q mutation's effects?

The D216Q mutation has been identified in malignant melanoma and affects Mg²⁺ sensing and feedback regulation of MRS2 . When studying this mutation:

• Use MRS2-F antibody to compare expression levels of wild-type versus D216Q mutant

• Examine whether the antibody epitope overlaps with the D216 region, which might affect detection

• Investigate conformational changes by combining antibody studies with limited proteolysis

• Assess how the mutation affects Mg²⁺-dependent changes in α-helicity, stability, and hydrodynamic radius

• Correlate antibody binding with functional studies showing that D216Q enhances mitochondrial Mg²⁺ uptake, cell migration, and resistance to apoptosis

How can researchers use MRS2-F antibody to investigate structure-function relationships in the MRS2 amino terminal domain?

The amino terminal domain (NTD) of MRS2 comprises ~71% of the mature protein and resides within the mitochondrial matrix . To study its role:

• Use domain-specific antibodies to track conformational changes

• Perform co-immunoprecipitation studies to identify NTD-interacting proteins

• Compare wild-type MRS2 with mutants affecting specific NTD regions

• Investigate how Mg²⁺ binding to the NTD affects its self-association into a homodimer

• Examine the relationship between NTD conformation and channel activity across the inner mitochondrial membrane

What are the optimal sample preparation techniques for MRS2-F antibody immunofluorescence microscopy?

For successful mitochondrial protein visualization:

• Fix cells with 4% paraformaldehyde to preserve mitochondrial morphology

• Use gentle permeabilization (0.1-0.2% Triton X-100) to maintain mitochondrial membrane integrity

• Block with 5% serum that matches the secondary antibody host species

• Co-stain with established mitochondrial markers (TOM20, MitoTracker) for colocalization studies

• Optimize primary antibody concentration through titration experiments (typically 1:100 to 1:1000)

• Consider using confocal or super-resolution microscopy for detailed localization studies

How should researchers modify Western blot protocols to detect both glycosylated and non-glycosylated MRS2 isoforms?

Based on research showing dual MRS2 isoforms :

• Use gradient gels (4-15%) to better separate the glycosylated (~55-60 kDa) and non-glycosylated (~45-50 kDa) isoforms

• Include positive controls from tissues known to express both isoforms (mouse liver, fibroblasts)

• Run paired samples with and without PNGase F treatment

• For blocking, use 5% non-fat milk or BSA depending on antibody specifications

• Optimize transfer conditions for high molecular weight proteins (lower voltage, longer time)

• Consider using fluorescent secondary antibodies for quantitative analysis of isoform ratios

What technical approaches can resolve contradictory results between antibody detection and functional MRS2 assays?

When facing discrepancies between antibody detection and functional studies:

• Assess whether post-translational modifications affect antibody binding

• Verify antibody specificity using multiple controls

• Consider that conformational changes induced by divalent cations may alter epitope accessibility

• Evaluate the impact of detergents (like CHAPS) used during sample preparation

• Remember that MRS2 function depends on its pentameric assembly, which may not be reflected in denatured Western blot samples

• Perform parallel experiments with multiple antibodies targeting different MRS2 regions

How can MRS2-F antibody be used to investigate the relationship between mitochondrial energy metabolism and MRS2 glycosylation?

Research suggests that MRS2 glycosylation correlates with cellular energy metabolism . To explore this:

• Use MRS2-F antibody to track glycosylation patterns in cells under different metabolic conditions

• Compare glycosylation status between cells grown in glucose versus galactose media

• Analyze changes after treatment with glycolytic inhibitors like 2-deoxyglucose

• Investigate the ratio of glycosylated to non-glycosylated MRS2 in mitochondrial respiratory chain disease patient fibroblasts

• Correlate glycosylation status with Mg²⁺ influx capacity and mitochondrial function

What approaches can researchers use to study MRS2 channel regulation mechanisms with MRS2-F antibody?

Recent structural and functional studies reveal that MRS2 is a Ca²⁺-regulated, non-selective channel . To investigate regulation:

• Use MRS2-F antibody to track conformational changes under different ionic conditions

• Combine with electrophysiological analyses to correlate structure with function

• Study the conserved arginine ring within the pore that restricts cation movements

• Investigate how the antibody binding is affected by Ca²⁺, which regulates channel function

• Compare human MRS2 with its prokaryotic ortholog CorA, which operates differently as a Mg²⁺-gated Mg²⁺ channel

How can researchers utilize MRS2-F antibody to investigate the role of MRS2 in cancer phenotypes?

The D216Q mutation identified in malignant melanoma provides insights into MRS2's role in cancer :

• Compare MRS2 expression levels between normal and cancerous tissues

• Investigate correlation between MRS2 expression/mutations and cancer progression

• Study how MRS2-mediated Mg²⁺ transport affects cell migration and apoptosis resistance

• Examine whether targeting MRS2 affects cancer cell survival

• Analyze whether the glycosylation status of MRS2 changes in cancer cells with altered metabolism

What are common pitfalls when using MRS2-F antibody and how can researchers address them?

Potential challenges include:

• Cross-reactivity with related proteins in the CorA/Mrs2/Alr1 family due to conserved motifs like GMN

• Interference from post-translational modifications affecting epitope accessibility

• Difficulty detecting native conformations in fixed samples

• Variability in mitochondrial isolation protocols affecting antibody performance

• Changes in MRS2 oligomerization state under different buffer conditions

Researchers should validate results with multiple techniques, include appropriate controls, and optimize protocols for specific applications.

How should researchers interpret changes in MRS2 detection across different experimental conditions?

When analyzing MRS2 expression changes:

• Consider the impact of Mg²⁺ and Ca²⁺ concentrations on protein conformation and epitope accessibility

• Account for changes in glycosylation status affecting apparent molecular weight

• Evaluate whether observed changes reflect altered expression, localization, or post-translational modifications

• Correlate antibody detection with functional measurements of mitochondrial Mg²⁺ transport

• Remember that MRS2 regulation involves complex feedback mechanisms through its NTD

What statistical approaches are recommended for quantifying MRS2 expression in comparative studies?

For robust quantitative analysis:

• Use at least three biological replicates per experimental condition

• Normalize MRS2 signal to appropriate mitochondrial loading controls

• Apply paired statistical tests when comparing treated versus untreated samples

• Consider the distribution of data and use appropriate parametric or non-parametric tests

• For correlation analyses between MRS2 levels and functional parameters, use regression models

• When analyzing glycosylation patterns, express results as the ratio of glycosylated to non-glycosylated forms

How can MRS2-F antibody contribute to understanding the structural basis of MRS2 channel gating?

Recent cryo-electron microscopy structures provide new insights into MRS2 structure :

• Use antibodies targeting specific domains to track conformational changes during gating

• Combine with site-directed mutagenesis of key residues identified in structural studies

• Investigate the pentameric channel architecture and mechanisms of ion permeation

• Study how Mg²⁺ binding to the NTD affects channel structure and function

• Compare human MRS2 structure with bacterial CorA for evolutionary insights

What role can MRS2-F antibody play in investigating mitochondrial disease mechanisms?

Mitochondrial diseases often involve disrupted ion homeostasis:

• Use MRS2-F antibody to compare MRS2 expression between healthy and diseased tissues

• Investigate changes in MRS2 glycosylation patterns in mitochondrial respiratory chain disease patient cells

• Study how pathological conditions affect the balance between glycosylated and non-glycosylated isoforms

• Correlate MRS2 alterations with mitochondrial dysfunction markers

• Examine whether therapeutic interventions targeting mitochondrial function affect MRS2 expression or modification

How might MRS2-F antibody be applied in developing novel therapeutics targeting mitochondrial magnesium transport?

Potential therapeutic applications include:

• Screening compounds that modulate MRS2 expression or function

• Developing targeted delivery systems for MRS2-modifying agents

• Studying the effects of existing drugs on MRS2 expression and magnesium transport

• Investigating whether MRS2 modulation can prevent mitochondrial dysfunction in disease models

• Exploring whether targeting the D216Q mutation could affect cancer phenotypes like enhanced cell migration and apoptosis resistance